With respect to canine cancers, activation of JAK/STAT pathways have been documented in diffuse large B cell lymphoma, osteosarcoma, metastatic mammary carcinoma, and hemangiosarcoma [12–15] suggesting that as with some human cancers, blockade of this pathway may have biologic activity in dogs. The gene discussed is SOAT1; the disease is osteosarcoma.